Sorafenib Tosylate

• Product NameSorafenib Tosylate
  CAS No.475207-59-1
  Purity
  Min QuantityKilograms
  Price~
• View Contact Detail

Detailed Description

Sorafenib Tosylate with CAS 475207-59-1 is co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar.

Sorafenib Tosylate (CAS 475207-59-1) is approved in the US for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.